ERBB2 and breast cancer: To provide a clinically and biologically relevant example, we performed a class comparison to identify the differently methylated CpGs among the four most common breast cancer subtypes (Basal-like, HER2+, Luminal A and Luminal B), using the nonparametric Kruskal–Wallis test.